Skip to main content
SpringerLink
Log in

Are SSRIs true antidepressant drugs? a plea for the re-evaluation of their therapeutic potential and safety.

  • Published:
Pharmacy World and Science Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Feighner JP, Robins E, Guze SB, Woodruff RA, Winokur G, Munoz R. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 1972;26:57‐63.

    Google Scholar 

  2. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria. Rationale and reliability. Arch Gen Psychiatry 1978;35:773‐82.

    Google Scholar 

  3. APA Task Force on DSM‐IV. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition. Washington, DC; American Psychiatric Association, 1994.

    Google Scholar 

  4. Guy W. ECDEU assessment manual for psychopharmacology. Revised ed, 1976. Washington, DC: US Department of Health, Education and Welfare, 1976.

    Google Scholar 

  5. Danish University Antidepressant Group. Paroxetine: a selec tive serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicentrer study. J Affect Disord 1990;18:289‐99.

    Google Scholar 

  6. Danish University Antidepressant Group. Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Psychopharmacology (Berl) 1986:90:131‐8.

    Google Scholar 

  7. Song F, Freemantle N, Sheldon TA, House A, Watson P, Long A, Mason J. Selective serotonin reuptake inhibitors: meta‐analysis of efficacy and acceptability. Brit Med J 1993:306:683‐7.

    Google Scholar 

  8. Montgomery SA, Henry J, McDonald G, Dinan T, Lader M, Hindmarch I, Clare A, Nutt D. Selective serotonin reuptake inhibitors: meta‐analysis of discontinuation rates. Int Clin Psychopharmacol 1994;9:47‐53.

    Google Scholar 

  9. Hoogendoorn D. Stijgend aantal gevallen van zelfmoord met veranderende methoden. Ned Tijdschr Geneeskd 1986;130:209‐12.

    Google Scholar 

  10. Van Harten J. Clinical pharmacokinetics of selective serotonin reuptake inhibitors. Clin Pharmacokinet 1993;24:203‐20.

    Google Scholar 

  11. Moleman P. Een vergelijking tussen drie serotonineheropnameremmers. Pharm Weekbl 1994;129:760‐5.

    Google Scholar 

  12. Den Boer JA, Westenberg HG, Effect of a serotonin and nora drenaline uptake inhibitor in panic disorder; a double‐blind comparative study with fluvoxamine and maprotiline. Int Clin Psychopharmacol 1988;3:59‐74.

    Google Scholar 

  13. Loonen AJM, Peer PGM, Zwanikken GJ. Continuation and maintenance therapy with antidepressive agents: a meta‐analysis of research. Pharm Weekbl [Sci] 1991:13;167‐75.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical pharmacologist, Central Pharmacy of the Godshuizen, P.O. Box 90,153, NL-5200 ME, 's-Hertogenbosch, The Netherlands

    Anton J.M. Kasteleijn‐Nolst TrenitÄ

Authors
  1. Anton J.M. Kasteleijn‐Nolst TrenitÄ
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kasteleijn‐Nolst TrenitÄ, A.J. Are SSRIs true antidepressant drugs? a plea for the re-evaluation of their therapeutic potential and safety.. Pharm World Sci 19, 70–72 (1997). https://doi.org/10.1023/A:1008669823508

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1008669823508

Keywords

Search

Navigation